JGL Scientific Advisory Board

It is composed of ten experts, internationally recognised in their fields of work - pharmacology, preclinical, clinical and regulatory stages of drug development, pharmaceutical product design, drug delivery systems and technologies, and practical regulatory and clinical and industrial experience.

The main goals for the SAB meeting

- Strengthen the scientific profile of the JGL research and development project / product portfolio
- Network and share relevant, science-based knowledge and ideas
- Review, challenge and advise the JGL team on ongoing R&D projects
- Provide scientific explanations and adequacy of performance data and plans
- Work with the JGL team and other SAB members to gather additional ideas for the portfolio and identify new projects with a sound scientific rationale
- Present the area of ​​own expertise through lectures and discussions
- Advise the JGL Board of Directors in special strategic decisions

Members

 

PROF. DR. SC. STIPAN JONJIĆ

Prof. dr. sc. Stipan Jonjić was born in 1953 and he is a professor and head of the Department of Histology and Embryology, and the head of the Center for Proteomics at the Medical Faculty of the University of Rijeka. His research interests include immunology, viral pathogenesis, vaccines and immunotherapy. In 2012, Jonjić became the first Croatian scientist to be admitted to Leopoldin, the German National Academy of Sciences, and in 2015 he was admitted to the European Academy of Microbiology. In 2006, he founded the Center for Proteomics, which has become one of the most recognizable scientific institutions in Croatia. He is the first Croatian scientist to receive a project in 2012 from the European Research Council (ERC), a scientific research body that funds projects solely on the basis of excellence. He has led projects at the U.S. National Institutes of Health and the Viral Immunology and Vaccine Science Center.

The work of prof. Jonjic resulted in a number of important discoveries in the field of viral immunology and vaccinology. He is the author of more than 250 scientific papers, many of which have been published in the most prestigious scientific journals, which makes him one of the most successful Croatian scientists. He has given more than 200 lectures at international scientific conferences and institutions around the world, and collaborates with a large number of world scientists in the field of viral immunology.

PROF. DR. SC. ÖZGEN ÖZER

Prof. dr. sc. Özgen Özer was born in 1962 in Ankara (Turkey), she is the head of the Department of Pharmaceutical Technology at the Faculty of Pharmacy of Ege University (Izmir, Turkey) where she received her doctorate in 1992. Her research interests include the design and formulation of dermal / transdermal products, the characterization and analysis of such products, liposomes, nanoparticles, stability, and the procedures required for the commercialization of product formulations.

She has a very successful scientific and mentoring career, 12 patents, more than 250 national and international presentations, publications in more than 150 publications, and research work in more than 50 projects, including eight awards for the best poster presentations, three best doctoral theses and the top five projects. He collaborates with a large number of eminent world scientists in the field of dermatology. Özer is the co-founder and CEO of Dermis Pharma Health and Cosmetic Products Inc. which was founded in 2016 in Turkey.

DR. SC. JAG AHLUWALIA

Dr. sc. Jag Ahluwalia is an experienced leader in the field of regulatory affairs and quality. In her rich professional career, leading positions in Ranbaxy (India), Pliva (Croatia), Xellia Pharmi (Denmark) and Kinedexe UK (own company) stand out.

Born in 1962 in Uganda, she holds a PhD in toxicology from the University of Surrey and has more than 35 years of experience in the pharmaceutical industry, from regulatory affairs, quality and product development, to business development. In 2014 she started three pharmaceutical companies in the UK, and her expertise lies in the successful launch of molecules that have been developed and registered using a virtual environment in a cost-effective way.

In the areas of industrial pharmaceutical practice and registration, she operates in the EU, the UK, the US, Canada, Asia, Australia and Latin America. Under her leadership, a number of projects have been successfully registered and launched, including FTF products in the United States. Thanks to her significant international experience, Jag Ahluwalia supports numerous projects of registration / entry of medicines into global markets.

PROF. DR. SC. VLADIMIR TRKULJA, DR. MED.

Prof. dr. sc. Vladimir Trkulja, MD is a professor of pharmacology at the Medical Faculty of the University of Zagreb. He finished primary and secondary school and the Faculty of Medicine in Zagreb. After completing his internship as a doctor, he participated in the Homeland War and then got a job at the Department of Pharmacology, Faculty of Medicine, University of Zagreb. He received his master's degree in 1995 and his doctorate in 1997.

He is an editor and reviewer in numerous scientific publications, and the author or co-author of 115 professional papers. He gained experience in drug development and regulation, evaluation of therapeutic interventions, pharmacokinetics and systematic reviews / meta-analyzes at the Center for Genetic Engineering and Biotechnology (Havana, Cuba), Baxter Healthcare International Renal Division (Chicago, USA), Serum Institute Pune, India), Fumedica GmbH (Herne, Germany), Genera (Zagreb, Croatia), Hindustan Antibiotics (Pune, India) and Elanex Pharma (Seattle, USA).

ASST.PROF.PH.D. SONJA JANDROKOVIĆ, MD

Asst.prof.ph.d. Sonja Jandroković, MD was born in 1969 in Beijing. She is the head of the Day Hospital and One-Day Surgery at the Clinic for Eye Diseases, University Hospital Center Zagreb. After graduating from the Medical Faculty of the University of Zagreb in 1993, she specialized in ophthalmology, and chose glaucomatology as her specialization. She received her PhD in 2017 in the study of "Biomedicine and Health" at the Faculty of Medicine, University of Zagreb.

She actively participates in numerous scientific and professional conferences in the country and abroad, as well as in first category courses and evaluated scientific lectures. 

She is the author or co-author of 16 scientific and professional papers and several publications in journals. From the academic year 2011/2012 she participates in the teaching of the Faculty of Medicine, University of Zagreb, and has also lectured at the university postgraduate specialist studies "Ophthalmology" and "Ophthalmology and Optometry". She is the co-leader of the "Glaucoma" course.

RALF G. SIBBING, M.PHARM.

Ralf G. Sibing, M.Pharm. is a partner and co-owner of TentaConsult Pharma/Med GmbH. He is a well-known and respected expert with extensive experience in the pharmaceutical industry. His expertise and professional interests focus on the development, regulation, and testing of medical devices, as well as the merging of regulations for both medical devices and drugs through Drug-Device Combination Products (DDCP). This area is critically important for JGL’s new products and existing ones that now fall under this category due to the EU Commission’s new regulations (e.g., nasal sprays). 

He was born on 4 November 1970 in Paderborn, Germany, and earned his pharmacy degree from the Westphalian Wilhelms University in Münster. His professional career began at Diapharm GmbH (1996-2020), where he served as executive director and shareholder, overseeing company development, strategy, the coordination of strategic projects, and employee development. After that, he joined TentaConsult, where he built a collaboration network, providing professional consulting services in the regulation of medical devices and medicinal products.

DR. SC. ANDREAS BILSTEIN

Born in 1974, Andreas Bilstein is an experienced scientist, consultant and CEO of Urastech with many years of experience in the pharmaceutical industry. His areas of interest include medical product development, business development, clinical trial management, biotechnology, and regulatory requirements and management. His professional career (2007-2019) is primarily related to the global company Bitop AG (Dortmund, Germany) where he was a member of the Executive Board and CEO of scientific and technological operations, responsible for new product development, research and development, quality management , regulatory affairs and production. Dr. Bilstein received his PhD in 2005 from the Institute of Biochemistry, Faculty of Medicine, University of Cologne.prof. 

PROF. SANDRA PETERNEL, MD

Prof. Sandra Peternel graduated from the Faculty of Medicine of the University of Rijeka in 2002.  She earned her doctorate in biomedical sciences in 2013 from the Faculty of Medicine at the University of Zagreb. From 2015 to 2016, she studied at the Department of Dermatopathology at the University of California, San Francisco (USA).

In 2013, she began working at the Department of Pharmacology and was promoted to assistant professor in 2014. Since 2019, she has been serving as an associate professor of dermatology and venereology at the Faculty of Medicine, University of Rijeka. Additionally, since 2013, she has been working as a specialist in dermatology and venereology at the Rijeka Clinical Hospital Centre.

She actively participates in numerous scientific and professional conferences both domestically and internationally, contributes to courses and scientific lectures, and serves as a reviewer for several scientific journals. From 2003 to 2021, she was a member of seven research projects, both Croatian and international. In the field of dermatology, she led three clinical studies as the principal investigator at her centre and currently serves as a consultant and external expert for the European Medicines Agency (EMA).

PROF. DR. SC. JASMINA LOVRIĆ

Prof. dr. sc. Jasmina Lovrić was born in 1977. She completed her studies in pharmacy at the Faculty of Pharmacy and Biochemistry, University of Zagreb (FBF) in 2001, and her doctorate in pharmaceutical sciences in 2006. During her doctoral studies, she spent three years at McGill University (Montreal, Canada). For her doctoral dissertation in 2006, she was awarded the prize of the Society of University Teachers and Other Scientists.

As a Research Fellow in 2006, she joined the FBF Department of Pharmaceutical Technology. Three years later, she acquired the scientific-teaching title of assistant professor, and in 2015 the scientific-teaching title of associate professor. Scientific activity of dr. sc. Lovrić resulted in the publication of 38 highly scientific papers, two chapters in scientific books and 60 conference papers. She is the supervisor of two doctoral theses, 34 diploma theses and five specialist theses.

Her special areas of expertise are technologies, characterization and delivery systems for products in ophthalmology. She was the Vice-Dean for Science and Research at the Faculty of Pharmacy and Biochemistry for two terms, and since October 2020 she has been the Dean of the Faculty of Pharmacy and Biochemistry.